The third phase of the COVID-19 vaccination was kicked off on May 1st in India. After healthcare workers, elderly people, and 45+. now people in the age group of 18-44 are getting vaccinated with two COVID-19 vaccines approved for use in India, Covaxin, and Covishield.
Currently, the government hasn’t allowed people to decide which vaccines they want to get, but the result of the first phase and second phase clearly suggests that both the vaccines being inoculated in India are safe and effective.
Getting vaccinated is important:
Both the vaccines have shown more than satisfactory results ever since the inoculation started in India. Over 8 crore Indian citizens have been successfully vaccinated and lakhs of doses are being exported to other countries as well. While both Covaxin and Covishield have been deemed safe for use, and adverse reactions have been rarely observed, there are also certain possible side effects people need to be aware of. However, getting vaccinated is of utmost priority. it’s really important.
Side effects of both vaccine :
Covaxin which has been developed by Hyderabad-based Bharat Biotech uses an inactive version of the virus. Some of the side effects which have been noticed till right now include redness in the arm, pain at the injection site, low-grade temperature, malaise, headache, vomiting, weakness, and fatigue.
The Oxford-Astrazeneca vaccine, marketed in India as Covishield is widely considered a safe vaccine to use. A person can develop some mild symptoms such as pain, warmth, itching, bruising, fatigue, chills, fever, nausea, muscle ache, lumps, and malaise.
In both vaccines After injecting the vaccine, you may experience pain at the site of injection. Some people also experience side effects such as headache, joint pain, which may feel feverish. These side effects do not persist for long and generally goes within a day or two.
Differences between Covaxin and Covishield :
- The interval between the 2 doses is 4-6 weeks
- This Covaxin can be 78-100% effective after the second dose
- Covaxin can be injected into younger people as well (12 years and above)
- Covaxin is more expensive and is being sold at INR 400 (government) and INR 1200 (private facilities)
- Fewer hospitals and healthcare centres are stocking Covaxin
- The interval between 1st and 2nd doses is 12-16 weeks
- Efficacy after the second dose can vary from 70-90%
- People above 18 years of age can take Covishield.
- Covishield is less expensive. SII is selling this vaccine at INR 300 (government) and INR 600 (private centres)
- Covishield is easy available
Covishield or Covaxin Efficacy:
Both the vaccines have shown more than satisfactory results ever since the inoculation started in India. The effectiveness of the Covishield is nearly 90% as per the global reports and Covaxin’s 81% according to interim 3rd phase trial results.
Who shouldn’t take Covaxin?
While people aren’t allowed to choose the COVID vaccine, either in India or outside, the ones who have certain pre-existing conditions have been asked to get a doctor’s consult before progressing.
Studies have shown that the Covaxin dose may be slightly unsafe for people who might be running a fever at the time of administration, are on blood-thinning medications, suffering from immune disorders, bleeding problems.
Who shouldn’t take Covishield?
As for Covishield, people with any pre-existing allergy should be careful. Those on blood-thinning medications and the ones planning to conceive are also being advised to wait right now. People who recently had COVID-19 should also consider postponing their turn for vaccination by up to 3-4 weeks.
Through all the information given above it is known that this injection is very important. Covaxin vs Covishield you can use either of the two vaccines, both are right vaccine, either one can get any vaccine .we request everyone should get vaccinated as soon as possible to avoid this covid-19
Also Read my article: